The effect of cyclosporin-A on peri-operative myocardial injury in adult patients undergoing coronary artery bypass graft surgery: A randomised controlled clinical trial

Heart

Volumn 100, Issue 7, 2014, Pages 544-549

  Hausenloy, D J ^a   Kunst, G ^b   Boston Griffiths, E ^a   Kolvekar, S ^a   Chaubey, S ^b   John, L ^b   Desai, J ^b   Yellon, D M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; CYCLOSPORIN A; PLACEBO; TROPONIN T;

AGED; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE ASSOCIATION; DRUG EFFICACY; ELECTIVE SURGERY; FEMALE; HEART INFARCTION; HEART MUSCLE INJURY; HEART PROTECTION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; OUTCOME ASSESSMENT; PERIOPERATIVE MYOCARDIAL INJURY; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION;

CARDIAC SURGERY; MYOCARDIAL ISCHAEMIA AND INFARCTION (IHD);

AGED; CORONARY ARTERY BYPASS; CYCLOSPORINE; DOUBLE-BLIND METHOD; FEMALE; HEART DISEASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PROSPECTIVE STUDIES;

EID: 84896546269     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-304845     Document Type: Article

References (17)

1. Croal BL, Hillis GS, Gibson PH, et al. Relationship between postoperative cardiac troponin I levels and outcome of cardiac surgery. Circulation 2006;114:1468-75. (Pubitemid 44527001)
2. Brener SJ, Lytle BW, Schneider JP, et al. Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality. J Am Coll Cardiol 2002;40:1961-7. (Pubitemid 35428831)
3. Fellahi JL, Gue X, Richomme X, et al. Short-and long-term prognostic value of postoperative cardiac troponin I concentration in patients undergoing coronary artery bypass grafting. Anesthesiology 2003;99:270-4. (Pubitemid 36909551)
4. Venugopal V, Ludman A, Yellon DM, et al. 'Conditioning' the heart during surgery. Eur J Cardiothorac Surg 2009;35:977-87.
5. Heusch G, Kleinbongard P, Bose D, et al. Coronary microembolization: from bedside to bench and back to bedside. Circulation 2009;120:1822-36.
6. Hausenloy DJ, Yellon DM. The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion. J Mol Cell Cardiol 2003;35:339-41. (Pubitemid 36411694)
7. Leung AW, Halestrap AP. Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore. Biochim Biophys Acta 2008;1777:946-52.
8. Hausenloy DJ, Maddock HL, Baxter GF, et al. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res 2002;55:534-43. (Pubitemid 34874948)
9. Hausenloy DJ, Duchen MR, Yellon DM. Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. Cardiovasc Res 2003;60:617-25. (Pubitemid 37501119)
10. Argaud L, Gateau-Roesch O, Muntean D, et al. Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury. J Mol Cell Cardiol 2005;38:367-74. (Pubitemid 40215206)
11. Piot C, Croisille P, Staat P, et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med 2008;359:473-81.
12. Hausenloy DJ, Boston-Griffiths EA, Yellon DM. Cyclosporin A and cardioprotection: from investigative tool to therapeutic agent. Br J Pharmacol 2012;165:1235-45.
13. Hausenloy DJ, Mwamure PK, Venugopal V, et al. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet 2007;370:575-9. (Pubitemid 47247853)
14. Schielzeth H, Forstmeier W. Conclusions beyond support: overconfident estimates in mixed models. Behav Ecol 2009;20:416-20.
15. Shanmuganathan S, Hausenloy DJ, Duchen MR, et al. Mitochondrial permeability transition pore as a target for cardioprotection in the human heart. Am J Physiol Heart Circ Physiol 2005;289:H237-42. (Pubitemid 40934105)
16. Osman MM, Lulic D, Glover L, et al. Cyclosporine-A as a neuroprotective agent against stroke: its translation from laboratory research to clinical application. Neuropeptides 2011;45:359-68.
17. Hausenloy DJ, Boston-Griffiths EA, Yellon DM. Cyclosporin A and cardioprotection: from investigative tool to therapeutic agent. Br J Pharmacol 2012;165:1235-45.